Active substanceAscorbic acid + RutosideAscorbic acid + Rutoside
Similar drugsTo uncover
  • Ascorutin
    pills inwards 
    ROSLEKS PHARM, LLC     Russia
  • Ascorutin
    pills inwards 
    VIFITEH, CJSC     Russia
  • Ascorutin
    pills inwards 
    LYUMI, LLC     Russia
  • Ascorutin
    pills inwards 
    OZONE, LLC     Russia
  • Ascorutin
    pills inwards 
    ORGANICS, JSC     Russia
  • Ascorutin
    pills inwards 
    ALTAYVITAMINS, CJSC     Russia
  • Ascorutin
    pills inwards 
    MEDISORB, CJSC     Russia
  • Ascorutin
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Ascorutin
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Ascorutin
    pills inwards 
  • Ascorutin
    pills inwards 
  • Ascorutin
    pills inwards 
    NGO Farmvilar, OOO     Russia
  • Ascorutin
    pills inwards 
  • Ascorutin D
    pills inwards 
    ROSFARM, CJSC     Russia
  • Ascorutin-UBF
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Dosage form: & nbsppills
    Composition:

    Composition (per one tablet)

    Active substances:

    Ascorbic acid - 0.05 g (in terms of 100% substance)

    Rutin (rutozide) - 0.05 g (in terms of 100% substance)

    Excipients:

    sucrose (white sugar), potato starch, low molecular weight polyvinylpyrrolidone 12600 ± 2700, colloidal silicon dioxide, calcium stearate.

    Description:

    Round tablets of flat-cylindrical shape with a facet and a risk, from light yellow to yellow with grayish or greenish tinge. Light and dark inclusions are allowed.

    Pharmacotherapeutic group:Vitamin
    ATX: & nbsp

    C.05.C.A.51   Rutozide in combination with other drugs

    Pharmacodynamics:

    Ascorbic acid is involved in the regulation of redox processes, carbohydrate metabolism, blood clotting, tissue regeneration, and improves the body's resistance.

    Rutozide (a derivative routine) eliminates the increased permeability of capillaries, strengthens the vascular wall, reducing its swelling and inflammation. It has an antiaggregant effect, which improves microcirculation.

    Pharmacokinetics:


    Indications:

    Hypo-and avitaminosis of ascorbic acid and rutozide. As part of complex therapy for varicose veins, trophic disorders and skin ulcers, with chronic venous insufficiency; with hemorrhagic diathesis.

    Contraindications:

    Increased individual sensitivity to the components of the drug; congenital intolerance to fructose, glucose-galactose malabsorption, sugar / isomaltase deficiency, children's age.

    Carefully:

    Conditions accompanied by hypercoagulable blood and a tendency to thrombosis, thrombophlebitis, diabetes mellitus.

    If you have any of these diseases, consult a doctor before taking the drug.

    Pregnancy and lactation:

    Due to the content of the drug routine it should not be used in the first trimester of pregnancy.

    When using the drug, it is necessary during pregnancy and lactation to observe the dosage and duration of the course of treatment prescribed by the doctor.
    Dosing and Administration:

    Inside, 1 tablet 2-3 times a day during or after a meal. The course of treatment is 2-3 weeks.

    Side effects:

    There may be allergic reactions (skin rash), dyspeptic disorders, headache.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    The use of excessive doses of the drug may cause nausea, vomiting, diarrhea, headache.

    Treatment: symptomatic, forced diuresis.

    Interaction:

    Ascorbic acid increases the absorption of drugs of the penicillin group,gland; reduces the clinical effect of heparin and indirect anticoagulants, which requires correction of doses when they are used simultaneously.

    Special instructions:

    Patients with diabetes should take into account that one tablet of the drug contains about 0.2 grams of carbohydrates (0.017 XE).

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the ability to perform potentially dangerous activities requiring increased concentration of attention and speed of psychomotor reactions (transport management, work with moving mechanisms).

    Form release / dosage:

    Tablets 50 mg + 50 mg.

    Packaging:

    For 10 tablets in a planar cell box made of polyvinylchloride film and aluminum foil with thermal lacquer coating.

    2, 3 or 5 contour cell packs, together with instructions for medical use, are placed in a pack of cardboard.

    Storage conditions:

    In the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years. Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-004876
    Date of registration:30.05.2018
    Expiration Date:30.05.2023
    The owner of the registration certificate:FARMTSENTR VILAR, ZAO FARMTSENTR VILAR, ZAO Russia
    Manufacturer: & nbsp
    Information update date: & nbsp21.06.2018
    Illustrated instructions
      Instructions
      Up